|
Volumn 79, Issue 3, 2008, Pages 454-
|
Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampin-based regimen
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
ANTIBIOTIC SENSITIVITY;
ANTIMICROBIAL THERAPY;
DEBRIDEMENT;
DISEASE ASSOCIATION;
HIP PROSTHESIS;
HUMAN;
LETTER;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
PATIENT SELECTION;
PROSTHESIS INFECTION;
RETROSPECTIVE STUDY;
RISK FACTOR;
TOTAL HIP PROSTHESIS;
TREATMENT DURATION;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ACUTE DISEASE;
HIP ARTHROPLASTY;
INFECTION;
MICROBIOLOGY;
NOTE;
ACUTE DISEASE;
ANTIBIOTICS, ANTITUBERCULAR;
ARTHROPLASTY, REPLACEMENT, HIP;
HUMANS;
PROSTHESIS-RELATED INFECTIONS;
RIFAMPIN;
RISK FACTORS;
TREATMENT OUTCOME;
|
EID: 47249132934
PISSN: 17453674
EISSN: 17453682
Source Type: Journal
DOI: 10.1080/17453670710015418 Document Type: Letter |
Times cited : (6)
|
References (0)
|